Tuan Trang, PhD, discusses biological differences in chronic pain between men and women

News
Video

Researchers have discovered that leptin, a hormone linked to energy metabolism, plays a crucial role in driving neuropathic pain in women but not in men, opening the door to targeted pain treatments.

In a recent interview with Contemporary OB/GYN, Tuan Trang, PhD, from the University of Calgary, discussed a study using pre-clinical rodent models to investigate the biological differences between men and women in experiencing neuropathic pain.

Neuropathic pain arises when the nervous system is damaged or not functioning properly because of injury or disease, leading to chronic and often debilitating pain. The researchers used both male and female rodents to explore potential differences in the underlying causes of this condition.

Their findings revealed a significant difference in the role of the immune system between the sexes. Specifically, they identified that a type of immune cell known as CD8+ T cells behaves differently in male and female rodents. In female rodents, these T cells enter the central nervous system and release leptin, a hormone typically associated with energy metabolism. However, in this context, leptin was found to contribute to neuropathic pain. Notably, this mechanism did not occur in male rodents, highlighting a fundamental biological distinction between the sexes in how neuropathic pain develops.

According to Trang, these findings have significant implications. First, they provide a deeper understanding of why men and women may experience chronic pain differently. Second, they identify leptin as a potential target for pain management, specifically in women. This discovery could lead to new therapeutic approaches aimed at reducing pain by targeting leptin. Additionally, leptin could serve as a biomarker to predict susceptibility to neuropathic pain in women.

Previous clinical studies had already observed that women with chronic pain conditions, such as fibromyalgia and arthritis, often have elevated leptin levels. However, the reason for this was unclear. Trang’s study bridges this gap by demonstrating that leptin plays a direct role in neuropathic pain, opening new possibilities for treatment strategies that specifically address pain in female patients.

This video is part 1 of a 2-part series. Check back tomorrow for part 2.

Reference

Fan CY, McAllister BB, Stokes-Heck S, et al. Divergent sex-specific pannexin-1 mechanisms in microglia and T cells underlie neuropathic pain. Neuron. 2025;113(6):896-911. doi:10.1016/j.neuron.2025.01.005

Recent Videos
Anietie Aliu, PhD, highlights racial barriers to breast cancer screening | Image Credit: bbc.com.
Anietie Aliu, PhD, discusses how to improve breast cancer screening disparities | Image Credit: bbc.com
How AI is revolutionizing breast cancer detection | Image Credit: simonmed.com
Understanding cardiovascular risk factors in women | Image Credit: cedars-sinai.org.
Christie Hilton, DO, discusses breast cancer management | Image Credit: findcare.ahn.org
Sheryl Kingsberg, PhD: Psychedelic RE104 for postpartum depression
Mammograms may reveal hidden cardiovascular risks, study finds | Image Credit: providers.ucsd.edu
Erika Hamilton highlights emerging breast cancer trends and advances in treatment | Image Credit: sarahcannon.com
Empowering women to take charge of their health | Image Credit: © piecesofi.com - © piecesofi.com - stock.adobe.com.
Related Content
© 2025 MJH Life Sciences

All rights reserved.